Literature DB >> 12376209

Population mixing, childhood leukaemia, CNS tumours and other childhood cancers in Yorkshire.

R C Parslow1, G R Law, R Feltbower, S E Kinsey, P A McKinney.   

Abstract

We tested the hypothesis that variation in population mixing attributable to the diversity of migrants moving to an area is associated with the incidence of childhood leukaemia and other childhood cancers. An ecological analysis was performed on 954 children (<15 years) diagnosed with a malignancy between 1986 and 1996 in 532 electoral wards in Yorkshire, UK. Incidence rate ratios (IRR) were calculated for all childhood leukaemias (n=325), acute lymphoblastic leukaemia (ALL) (n=248), central nervous system (CNS) tumours (n=236) and other solid tumours (n=393) Incidence of all childhood leukaemias was significantly lower in areas of high (top decile) population mixing (IRR 0.72, 95% Confidence Interval (CI) 0.54-0.97) and higher in areas of low (bottom decile) population mixing (IRR 1.56, 95% CI 0.73-3.34), but similar patterns of incidence were not observed for central nervous system or other solid tumours. Population mixing may be a proxy for the range of infections circulating in a community and these results are consistent with the hypothesis that greater exposure to infections reduces the risk of developing childhood leukaemia by conferring efficient modulation of the immune system.

Entities:  

Mesh:

Year:  2002        PMID: 12376209     DOI: 10.1016/s0959-8049(02)00316-7

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  13 in total

1.  Childhood cancer and power lines: results do not support causal role for electromagnetic fields.

Authors:  Sarah J Hepworth; Richard G Feltbower; Roger C Parslow; Patricia A McKinney
Journal:  BMJ       Date:  2005-09-17

2.  Does population mixing measure infectious exposure in children at the community level?

Authors:  John C Taylor; Graham R Law; Paul J Boyle; Zhiqiang Feng; Mark S Gilthorpe; Roger C Parslow; Gavin Rudge; Richard G Feltbower
Journal:  Eur J Epidemiol       Date:  2008-08-14       Impact factor: 8.082

3.  Population mixing and the risk of childhood leukaemia in Switzerland: a census-based cohort study.

Authors:  Judith E Lupatsch; Claudia E Kuehni; Felix Niggli; Roland A Ammann; Matthias Egger; Ben D Spycher
Journal:  Eur J Epidemiol       Date:  2015-05-26       Impact factor: 8.082

4.  Temporal association between childhood leukaemia and population growth in Swiss municipalities.

Authors:  Judith E Lupatsch; Christian Kreis; Marcel Zwahlen; Felix Niggli; Roland A Ammann; Claudia E Kuehni; Ben D Spycher
Journal:  Eur J Epidemiol       Date:  2016-06-01       Impact factor: 8.082

5.  An examination, with a meta-analysis, of studies of childhood leukaemia in relation to population mixing.

Authors:  L J Kinlen
Journal:  Br J Cancer       Date:  2012-09-06       Impact factor: 7.640

6.  Population mixing, socioeconomic status and incidence of childhood acute lymphoblastic leukaemia in England and Wales: analysis by census ward.

Authors:  C A Stiller; M E Kroll; P J Boyle; Z Feng
Journal:  Br J Cancer       Date:  2008-02-05       Impact factor: 7.640

7.  Childhood leukaemia and population movements in France, 1990-2003.

Authors:  S Bellec; B Baccaïni; A Goubin; J Rudant; M Ripert; D Hémon; J Clavel
Journal:  Br J Cancer       Date:  2007-12-18       Impact factor: 7.640

8.  Childhood leukaemia incidence and the population mixing hypothesis in US SEER data.

Authors:  D Wartenberg; D Schneider; S Brown
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

9.  Childhood leukaemia incidence and the population mixing hypothesis in US SEER data.

Authors:  R C Parslow; G R Law; R G Feltbower; P A McKinney
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640

10.  Socioeconomic status and other characteristics in childhood leukemia.

Authors:  H Hashemizadeh; H Boroumand; R Noori; M Darabian
Journal:  Iran J Ped Hematol Oncol       Date:  2013-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.